Medgenesis Inc. The spinoff will occur once final approval has been received from the Securities and Exchange Commission, Dunn said. The deal seems like a good opportunity to meet the needs of both companies, Dunn said.
Most people involved think it s a win-win situation.
Dunn said company officials expect the stock value to improve once the SEC approves the Medgenesis spinoff. Copyright 2001 Finance and Commerce. All rights reserved. A Dolan Media Publication.